(FSK) FS KKR Capital - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US3026352068
Stock: Debt Investments, Credit Solutions, Equity Interests, Corporate Bonds
Total Rating 23
Risk 60
Buy Signal -1.89
| Risk 5d forecast | |
|---|---|
| Volatility | 56.1% |
| Relative Tail Risk | -2.42% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.85 |
| Alpha | -57.55 |
| Character TTM | |
|---|---|
| Beta | 0.680 |
| Beta Downside | 1.078 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.12% |
| CAGR/Max DD | -0.04 |
EPS (Earnings per Share)
Revenue
Description: FSK FS KKR Capital March 05, 2026
FS KKR Capital Corp. (FSK) is a business development company (BDC) focused on debt investments. BDCs are regulated investment companies that provide capital to small and mid-sized companies, often those unable to access traditional bank financing.
FSK primarily invests in senior secured debt and, to a lesser extent, subordinated debt of private U.S. middle-market companies. These companies typically have annual revenues between $10 million and $2.5 billion, with a focus on those generating $50 million to $150+ million in EBITDA.
The company acquires loan interests through both secondary market transactions and direct primary investments. They target first lien and second lien secured loans, and occasionally mezzanine loans. As part of debt investments, FSK often receives equity interests like warrants or options.
FSK avoids investments in start-up companies, turnaround situations, or businesses with speculative plans. The company exits investments through private negotiation, repayment, IPOs, mergers, sales, or recapitalizations. Readers can find more detailed financial metrics and comparative analyses on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 11.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -13.36 > 1.0 |
| NWC/Revenue: -11.82% < 20% (prev 50.36%; Δ -62.18% < -1%) |
| CFO/TA -0.02 > 3% & CFO -235.0m > Net Income 11.0m |
| Net Debt (7.45b) to EBITDA (232.0m): 32.12 < 3 |
| Current Ratio: 0.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (280.1m) vs 12m ago 0.00% < -2% |
| Gross Margin: 41.58% > 18% (prev 0.59%; Δ 4099 % > 0.5%) |
| Asset Turnover: 5.27% > 50% (prev 7.81%; Δ -2.54% > 0%) |
| Interest Coverage Ratio: 0.90 > 6 (EBITDA TTM 232.0m / Interest Expense TTM 464.0m) |
Altman Z'' -1.08
| A: -0.01 (Total Current Assets 181.0m - Total Current Liabilities 268.0m) / Total Assets 13.73b |
| B: -0.24 (Retained Earnings -3.35b / Total Assets 13.73b) |
| C: 0.03 (EBIT TTM 417.0m / Avg Total Assets 13.97b) |
| D: -0.42 (Book Value of Equity -3.33b / Total Liabilities 7.88b) |
| Altman-Z'' Score: -1.08 = CCC |
Beneish M
| DSRI: 1.66 (Receivables 411.0m/373.0m, Revenue 736.0m/1.11b) |
| GMI: 1.42 (GM 41.58% / 58.92%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 0.66 (Revenue 736.0m / 1.11b) |
| TATA: 0.02 (NI 11.0m - CFO -235.0m) / TA 13.73b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of FSK shares?
As of March 07, 2026, the stock is trading at USD 10.69 with a total of 3,943,393 shares traded.
Over the past week, the price has changed by -1.02%, over one month by -16.87%, over three months by -31.21% and over the past year by -43.93%.
Over the past week, the price has changed by -1.02%, over one month by -16.87%, over three months by -31.21% and over the past year by -43.93%.
Is FSK a buy, sell or hold?
FS KKR Capital has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold FSK.
- StrongBuy: 1
- Buy: 0
- Hold: 8
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the FSK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.7 | 37.1% |
| Analysts Target Price | 14.7 | 37.1% |
FSK Fundamental Data Overview March 03, 2026
P/E Trailing = 11.0204
P/E Forward = 5.0942
P/S = 1.9913
P/B = 0.4911
Revenue TTM = 736.0m USD
EBIT TTM = 417.0m USD
EBITDA TTM = 232.0m USD
Long Term Debt = 7.36b USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 7.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.45b USD (from netDebt column, last quarter)
Enterprise Value = 10.48b USD (3.02b + Debt 7.63b - CCE 181.0m)
Interest Coverage Ratio = 0.90 (Ebit TTM 417.0m / Interest Expense TTM 464.0m)
EV/FCF = 1000.0x (Enterprise Value 10.48b / FCF TTM 1.00m)
FCF Yield = 0.01% (FCF TTM 1.00m / Enterprise Value 10.48b)
FCF Margin = 0.14% (FCF TTM 1.00m / Revenue TTM 736.0m)
Net Margin = 1.49% (Net Income TTM 11.0m / Revenue TTM 736.0m)
Gross Margin = 41.58% ((Revenue TTM 736.0m - Cost of Revenue TTM 430.0m) / Revenue TTM)
Gross Margin QoQ = 61.24% (prev 66.28%)
Tobins Q-Ratio = 0.76 (Enterprise Value 10.48b / Total Assets 13.73b)
Interest Expense / Debt = 1.51% (Interest Expense 115.0m / Debt 7.63b)
Taxrate = 21.0% (US default 21%)
NOPAT = 329.4m (EBIT 417.0m * (1 - 21.00%))
Current Ratio = 0.68 (Total Current Assets 181.0m / Total Current Liabilities 268.0m)
Debt / Equity = 1.31 (Debt 7.63b / totalStockholderEquity, last quarter 5.85b)
Debt / EBITDA = 32.12 (Net Debt 7.45b / EBITDA 232.0m)
Debt / FCF = 7453 (out of range, set to none) (Net Debt 7.45b / FCF TTM 1.00m)
Total Stockholder Equity = 6.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.08% (Net Income 11.0m / Total Assets 13.73b)
RoE = 0.18% (Net Income TTM 11.0m / Total Stockholder Equity 6.17b)
RoCE = 3.08% (EBIT 417.0m / Capital Employed (Equity 6.17b + L.T.Debt 7.36b))
RoIC = 2.34% (NOPAT 329.4m / Invested Capital 14.06b)
WACC = 3.24% (E(3.02b)/V(10.66b) * Re(8.42%) + D(7.63b)/V(10.66b) * Rd(1.51%) * (1-Tc(0.21)))
Discount Rate = 8.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.00%
[DCF] Terminal Value 84.73% ; FCFF base≈761.0m ; Y1≈657.2m ; Y5≈518.9m
[DCF] Fair Price = 29.70 (EV 15.77b - Net Debt 7.45b = Equity 8.32b / Shares 280.1m; r=5.90% [WACC]; 5y FCF grow -16.62% → 2.90% )
EPS Correlation: -70.03 | EPS CAGR: -8.31% | SUE: -0.86 | # QB: 0
Revenue Correlation: 7.75 | Revenue CAGR: -9.11% | SUE: -1.45 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.43 | Chg7d=-0.103 | Chg30d=-0.103 | Revisions Net=-6 | Analysts=7
EPS current Year (2026-12-31): EPS=1.71 | Chg7d=-0.382 | Chg30d=-0.383 | Revisions Net=-9 | Growth EPS=-26.8% | Growth Revenue=-19.0%
EPS next Year (2027-12-31): EPS=1.68 | Chg7d=-0.359 | Chg30d=-0.359 | Revisions Net=-1 | Growth EPS=-1.9% | Growth Revenue=-1.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -0.7% (Discount Rate 8.4% - Earnings Yield 9.1%)
[Growth] Growth Spread = -21.9% (Analyst -22.6% - Implied -0.7%)
P/E Forward = 5.0942
P/S = 1.9913
P/B = 0.4911
Revenue TTM = 736.0m USD
EBIT TTM = 417.0m USD
EBITDA TTM = 232.0m USD
Long Term Debt = 7.36b USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 7.63b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.45b USD (from netDebt column, last quarter)
Enterprise Value = 10.48b USD (3.02b + Debt 7.63b - CCE 181.0m)
Interest Coverage Ratio = 0.90 (Ebit TTM 417.0m / Interest Expense TTM 464.0m)
EV/FCF = 1000.0x (Enterprise Value 10.48b / FCF TTM 1.00m)
FCF Yield = 0.01% (FCF TTM 1.00m / Enterprise Value 10.48b)
FCF Margin = 0.14% (FCF TTM 1.00m / Revenue TTM 736.0m)
Net Margin = 1.49% (Net Income TTM 11.0m / Revenue TTM 736.0m)
Gross Margin = 41.58% ((Revenue TTM 736.0m - Cost of Revenue TTM 430.0m) / Revenue TTM)
Gross Margin QoQ = 61.24% (prev 66.28%)
Tobins Q-Ratio = 0.76 (Enterprise Value 10.48b / Total Assets 13.73b)
Interest Expense / Debt = 1.51% (Interest Expense 115.0m / Debt 7.63b)
Taxrate = 21.0% (US default 21%)
NOPAT = 329.4m (EBIT 417.0m * (1 - 21.00%))
Current Ratio = 0.68 (Total Current Assets 181.0m / Total Current Liabilities 268.0m)
Debt / Equity = 1.31 (Debt 7.63b / totalStockholderEquity, last quarter 5.85b)
Debt / EBITDA = 32.12 (Net Debt 7.45b / EBITDA 232.0m)
Debt / FCF = 7453 (out of range, set to none) (Net Debt 7.45b / FCF TTM 1.00m)
Total Stockholder Equity = 6.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.08% (Net Income 11.0m / Total Assets 13.73b)
RoE = 0.18% (Net Income TTM 11.0m / Total Stockholder Equity 6.17b)
RoCE = 3.08% (EBIT 417.0m / Capital Employed (Equity 6.17b + L.T.Debt 7.36b))
RoIC = 2.34% (NOPAT 329.4m / Invested Capital 14.06b)
WACC = 3.24% (E(3.02b)/V(10.66b) * Re(8.42%) + D(7.63b)/V(10.66b) * Rd(1.51%) * (1-Tc(0.21)))
Discount Rate = 8.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.00%
[DCF] Terminal Value 84.73% ; FCFF base≈761.0m ; Y1≈657.2m ; Y5≈518.9m
[DCF] Fair Price = 29.70 (EV 15.77b - Net Debt 7.45b = Equity 8.32b / Shares 280.1m; r=5.90% [WACC]; 5y FCF grow -16.62% → 2.90% )
EPS Correlation: -70.03 | EPS CAGR: -8.31% | SUE: -0.86 | # QB: 0
Revenue Correlation: 7.75 | Revenue CAGR: -9.11% | SUE: -1.45 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.43 | Chg7d=-0.103 | Chg30d=-0.103 | Revisions Net=-6 | Analysts=7
EPS current Year (2026-12-31): EPS=1.71 | Chg7d=-0.382 | Chg30d=-0.383 | Revisions Net=-9 | Growth EPS=-26.8% | Growth Revenue=-19.0%
EPS next Year (2027-12-31): EPS=1.68 | Chg7d=-0.359 | Chg30d=-0.359 | Revisions Net=-1 | Growth EPS=-1.9% | Growth Revenue=-1.9%
[Analyst] Revisions Ratio: -1.00 (0 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -0.7% (Discount Rate 8.4% - Earnings Yield 9.1%)
[Growth] Growth Spread = -21.9% (Analyst -22.6% - Implied -0.7%)